Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2008 (2008), Article ID 564127, 10 pages
http://dx.doi.org/10.1155/2008/564127
Research Article

Protein Alterations in Infiltrating Ductal Carcinomas of the Breast as Detected by Nonequilibrium pH Gradient Electrophoresis and Mass Spectrometry

1Laboratoire d'Immuno-Oncologie Moléculaire, Faculté de Médecine de Monastir, 5019 Monastir, Tunisia
2Institut Supérieur de Biotechnologie de Monastir, 5000 Monastir, Tunisia
3Plate Forme Protéomique, Institut de Biologie Moléculaire et Cellulaire, CNRS, 67084 Strasbourg, France
4Departement de Pathologie, Centre Hospitalo-Universitaire Farhat-Hached, 4002 Sousse, Tunisia
5Laboratoire Cytopath, 4000 Sousse, Tunisia
6Immunologie et Chimie thérapeutiques, UPR 9021-CNRS, Institut de Biologie Moléculaire et Cellulaire, 67084 Strasbourg, France
7Department of Genetic Medicine, Weill Cornell Medical College in Qatar, and Qatar Foundation, Doha, Qatar

Received 8 April 2007; Revised 20 November 2007; Accepted 19 January 2008

Academic Editor: Halima Bensmail

Copyright © 2008 Maria Kabbage et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, A. Thomas, T. Murray, and M. Thun, “Cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 52, no. 1, pp. 23–47, 2002. View at Google Scholar
  2. D. M. Parkin, J. Ferlay, M. Hamdi Cherif et al., Cancer in Africa: Epidemiology and Prevention, IARC Scientific Publications, IARC Press, Lyon, France, 2003.
  3. H. Hondermarck, “Breast cancer: when proteomics challenges biological complexity,” Molecular & Cellular Proteomics, vol. 2, pp. 281–291, 2003. View at Publisher · View at Google Scholar
  4. Q.-Y. He, J. Chen, H.-F. Kung, A. P.-W. Yuen, and J.-F. Chiu, “Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics,” Proteomics, vol. 4, no. 1, pp. 271–278, 2004. View at Publisher · View at Google Scholar
  5. J. D. Wulfkuhle, D. C. Sgroi, H. Krutzsch et al., “Proteomics of human breast ductal carcinoma in situ,” Cancer Research, vol. 62, no. 22, pp. 6740–6749, 2002. View at Google Scholar
  6. A. Görg, W. Weiss, and M. J. Dunn, “Current two-dimensional electrophoresis technology for proteomics,” Proteomics, vol. 4, no. 12, pp. 3665–3685, 2004. View at Publisher · View at Google Scholar
  7. B. R. Herbert, C. Sanchez, and L. Bin, “Two dimensional electrophoresis: the state of the art and future directions,” in Proteome Research: New Frontiers in Functional Genomics, M. R. Wilkins, K. I. Williams, R. D. Appel, and D. F. Hochstrasser, Eds., pp. 13–33, Springer, New York, NY, USA, 1997. View at Google Scholar
  8. P. Z. O'Farrell, H. M. Goodman, and P. H. O'Farrell, “High resolution two-dimensional electrophoresis of basic as well as acidic proteins,” Cell, vol. 12, no. 4, pp. 1133–1142, 1977. View at Publisher · View at Google Scholar
  9. K. Chahed, M. Kabbage, L. Ehret-Sabatier et al., “Expression of fibrinogen E-fragment and fibrin E-fragment is inhibited in the human infiltrating ductal carcinoma of the breast: the two-dimensional electrophoresis and MALDI-TOF-mass spectrometry analyses,” International Journal of Oncology, vol. 27, no. 5, pp. 1425–1431, 2005. View at Google Scholar
  10. L. H. Sobin and I. D. Fleming, “TNM classification of malignant tumors,fifth edition. Union Internationale Contre le Cancer and the American Joint Committee on Cancer,” Cancer, vol. 80, no. 9, pp. 1803–1804, 1997. View at Google Scholar
  11. C. W. Elston and I. O. Ellis, “Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up,” Histopathology, vol. 19, no. 5, pp. 403–410, 1991. View at Publisher · View at Google Scholar
  12. L. S. Ramagli and L. U. Rodriguez, “Quantification of microgram amounts of proteins in two-dimensional polyacrylamide gel electrophoresis sample buffer,” Electrophoresis, vol. 6, no. 11, pp. 559–563, 1985. View at Publisher · View at Google Scholar
  13. V. Neuhoff, R. Stamm, and H. Eibl, “Clear background and highly sensitive protein staining with Coomassie Blue dyes in polyacrylamide gels: a systematic analysis,” Electrophoresis, vol. 6, no. 9, pp. 427–448, 1985. View at Publisher · View at Google Scholar
  14. E. Schauenstein, H. Rabl, W. Steinschifter, C. Hirschmann, W. Estelberger, and K. Schauenstein, “Selective decrease of serum immunoglobulin G1 as a marker of malignant transformation in colorectal tissue,” Cancer, vol. 79, no. 8, pp. 1482–1486, 1997. View at Publisher · View at Google Scholar
  15. Y. Chen, Y.-Z. Zhang, Z.-G. Zhou, G. Wang, and Z.-N. Yi, “Identification of differently expressed genes in human colorectal adenocarcinoma,” World Journal of Gastroenterology, vol. 12, no. 7, pp. 1025–1032, 2006. View at Google Scholar
  16. E. Schauenstein, M. Lahousen, M. Weblacher, W. Steinschifter, W. Estelberger, and K. Schauenstein, “Selective decrease in serum immunoglobulin G1: a tissue nonspecific tumor marker detecting early stages of gynecologic malignant disease with high efficiency,” Cancer, vol. 78, no. 3, pp. 511–516, 1996. View at Publisher · View at Google Scholar
  17. W. Anderhuber, W. Steinschifter, A. Gotschuli, E. Schauenstein, and K. Schauenstein, “Quantitative changes in the immunoglobulin G subclass system—a reliable tumor marker in squamous epithelial carcinoma in the area of the head-neck,” Laryngorhinootologie, vol. 77, no. 10, pp. 564–568, 1998. View at Google Scholar
  18. L. Kronberger, W. Steinschifter, M. Weblacher et al., “Selective decrease of serum immunoglobulin G1 as marker for early stages of invasive breast cancer,” Breast Cancer Research and Treatment, vol. 64, no. 2, pp. 193–199, 2000. View at Publisher · View at Google Scholar
  19. P. Felsner, W. Steinschifter, M. Fischer et al., “The tumor-associated shift in immunoglobulin G1/G2 is expressed at the messenger RNA level of peripheral blood B lymphocytes in patients with gynecologic malignancies,” Cancer, vol. 88, no. 2, pp. 461–467, 2000. View at Publisher · View at Google Scholar
  20. Y. Kawano, T. Noma, and J. Yata, “Regulation of human IgG subclass production by cytokines: IFN-γ and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2,” Journal of Immunology, vol. 153, no. 11, pp. 4948–4958, 1994. View at Google Scholar
  21. K. Jurianz, S. Ziegler, N. Donin, Y. Reiter, Z. Fishelson, and M. Kirschfink, “K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement,” International Journal of Cancer, vol. 93, no. 6, pp. 848–854, 2001. View at Publisher · View at Google Scholar
  22. T. A. Caragine, N. Okada, A. B. Frey, and S. Tomlinson, “A tumor-expressed inhibitor of the early but not late complement lytic pathway enhances tumor growth in a rat model of human breast cancer,” Cancer Research, vol. 62, no. 4, pp. 1110–1115, 2002. View at Google Scholar
  23. K. Lorenz, M. J. Lohse, and U. Quitterer, “Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2,” Nature, vol. 426, no. 6966, pp. 574–579, 2003. View at Publisher · View at Google Scholar
  24. K. Yeung, P. Janosch, B. McFerran et al., “Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the Raf kinase inhibitor protein,” Molecular and Cellular Biology, vol. 20, no. 9, pp. 3079–3085, 2000. View at Publisher · View at Google Scholar
  25. K. Emoto, N. Toyama-Sorimachi, H. Karasuyama, K. Inoue, and M. Umeda, “Exposure of phosphatidylethanolamine on the surface of apoptotic cells,” Experimental Cell Research, vol. 232, no. 2, pp. 430–434, 1997. View at Publisher · View at Google Scholar
  26. X. Wang, N. Li, B. Liu et al., “A novel human phosphatidylethanolamine-binding protein resists tumor necrosis factor a-induced apoptosis by inhibiting mitogen-activated protein kinase pathway activation and phosphatidylethanolamine externalization,” Journal of Biological Chemistry, vol. 279, no. 44, pp. 45855–45864, 2004. View at Publisher · View at Google Scholar
  27. X. Wang, N. Li, H. Li et al., “Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-a-induced apoptosis and cell growth arrest,” Clinical Cancer Research, vol. 11, no. 20, pp. 7545–7553, 2005. View at Publisher · View at Google Scholar
  28. B. Sherry, N. Yarlett, A. Strupp, and A. Cerami, “Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 8, pp. 3511–3515, 1992. View at Publisher · View at Google Scholar
  29. C. Melle, D. Osterloh, G. Ernst, B. Schimmel, A. Bleul, and F. von Eggeling, “Identification of proteins from colorectal cancer tissue by two-dimensional gel electrophoresis and SELDI mass spectrometry,” International Journal of Molecular Medicine, vol. 16, no. 1, pp. 11–17, 2005. View at Google Scholar
  30. M. Li, Q. Zhai, U. Bharadwaj et al., “Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147,” Cancer, vol. 106, no. 10, pp. 2284–2294, 2006. View at Publisher · View at Google Scholar
  31. M. D. Wheeler, O. M. Smutney, and R. J. Samulski, “Secretion of extracellular superoxide dismutase from muscle transduced with recombinant adenovirus inhibits the growth of B16 melanomas in mice,” Molecular Cancer Research, vol. 1, no. 12, pp. 871–881, 2003. View at Google Scholar
  32. J. Chen, Q.-Y. He, A. P.-W. Yuen, and J.-F. Chiu, “Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis,” Proteomics, vol. 4, no. 8, pp. 2465–2475, 2004. View at Publisher · View at Google Scholar
  33. O. Trabold, S. Wagner, C. Wicke et al., “Lactate and oxygen constitute a fundamental regulatory mechanism in wound healing,” Wound Repair and Regeneration, vol. 11, no. 6, pp. 504–509, 2003. View at Publisher · View at Google Scholar
  34. W. Wang, G. Mouneimne, M. Sidani et al., “The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors,” Journal of Cell Biology, vol. 173, no. 3, pp. 395–404, 2006. View at Publisher · View at Google Scholar
  35. C. T. Yap, T. I. Simpson, T. Pratt, D. J. Price, and S. K. Maciver, “The motility of glioblastoma tumour cells is modulated by intracellular cofilin expression in a concentration-dependent manner,” Cell Motility and the Cytoskeleton, vol. 60, no. 3, pp. 153–165, 2005. View at Publisher · View at Google Scholar
  36. D. Dang, J. R. Bamburg, and D. M. Ramos, “αvβ3 integrin and cofilin modulate K1735 melanoma cell invasion,” Experimental Cell Research, vol. 312, no. 4, pp. 468–477, 2006. View at Publisher · View at Google Scholar
  37. J. G. Kiang and G. C. Tsokos, “Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology,” Pharmacology & Therapeutics, vol. 80, no. 2, pp. 183–201, 1998. View at Publisher · View at Google Scholar
  38. I. Korneeva, A. M. Bongiovanni, M. Girotra, T. A. Caputo, and S. S. Witkin, “IgA antibodies to the 27 kDa heat-shock protein in the genital tracts of women with gynecologic cancers,” International Journal of Cancer, vol. 87, no. 6, pp. 824–828, 2000. View at Publisher · View at Google Scholar
  39. C. Sarto, C. Valsecchi, F. Magni et al., “Expression of heat shock protein 27 in human renal cell carcinoma,” Proteomics, vol. 4, no. 8, pp. 2252–2260, 2004. View at Publisher · View at Google Scholar
  40. A. Parcellier, E. Schmitt, M. Brunet, A. Hammann, E. Solary, and C. Garrido, “Small heat shock proteins HSP27 and αB-crystallin: cytoprotective and oncogenic functions,” Antioxidants & Redox Signaling, vol. 7, no. 3-4, pp. 404–413, 2005. View at Publisher · View at Google Scholar
  41. M. C. Kamradt, F. Chen, and V. L. Cryns, “The small heat shock protein αB-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation,” Journal of Biological Chemistry, vol. 276, no. 19, pp. 16059–16063, 2001. View at Publisher · View at Google Scholar
  42. M. C. Kamradt, M. Lu, M. E. Werner et al., “The small heat shock protein aB-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3,” Journal of Biological Chemistry, vol. 280, no. 12, pp. 11059–11066, 2005. View at Publisher · View at Google Scholar